GEN Exclusives

More »

GEN News Highlights

More »
Apr 17, 2007

Pharmacopeia Earns $1M from Schering-Plough

  • Schering-Plough selected the first compound from its collaboration with Pharmacopeia for preclinical development. This step triggers a $1-million milestone payment to Pharmacopeia.

    "This novel compound and its promising attributes were the basis for the extension of our collaboration with Schering-Plough last fall," states Les Browne, Ph.D., president and CEO of Pharmacopeia.

    Schering-Plough is solely responsible for further development and commercialization of these candidates. However, Pharmacopeia is eligible to receive additional milestone payments related to the successful advancement of these programs and will also receive royalties on sales of any therapeutic products resulting from these programs.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »